Steve Schonfeld’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$102K Buy
+16,132
New +$112K ﹤0.01% 2491
2024
Q3
– Sell
-81,411
Closed -$1.16M – 2426
2024
Q2
$1.16M Buy
81,411
+52,460
+181% +$746K 0.01% 1132
2024
Q1
$410K Buy
+28,951
New +$409K ﹤0.01% 1544

Other funds holding TRDA

Steve Schonfeld's TRDA Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Entrada Therapeutics (TRDA) in Q3 2026: 16,132 shares worth $102K. The stake represents ﹤0.01% of the portfolio and ranks #2491 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in TRDA as recently as Q2 2024.

Steve Schonfeld first reported a position in TRDA in Q1 2024 and has held it in 3 quarters since. The position peaked at $1.16M in Q2 2024. 132 funds tracked by Wall St. Rank hold TRDA as of Q3 2026.

  • Steve Schonfeld held 16,132 shares of Entrada Therapeutics worth $102K as of Q3 2026.
  • Entrada Therapeutics was a new Steve Schonfeld position in Q3 2026.
  • Entrada Therapeutics made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #2491 holding.
  • Steve Schonfeld first reported a position in Entrada Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • Steve Schonfeld's Entrada Therapeutics position peaked at $1.16M in Q2 2024.
  • 132 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.